دورية أكاديمية
أعرض في EDS

Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review.

التفاصيل البيبلوغرافية
العنوان: Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review.
المؤلفون: Ermakov EA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia., Mednova IA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Boiko AS; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia., Buneva VN; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia., Ivanova SA; Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 22; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 22.
نوع المنشور: Systematic Review; Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Schizophrenia*/genetics, Animals ; Mice ; Neuroinflammatory Diseases ; Chemokines/metabolism ; Cytokines/metabolism ; Chemokine CCL2/metabolism ; Chemokine CCL4 ; Chemotaxis, Leukocyte ; Chemokine CCL5
مستخلص: Chemokines are known to be immunoregulatory proteins involved not only in lymphocyte chemotaxis to the site of inflammation, but also in neuromodulation, neurogenesis, and neurotransmission. Multiple lines of evidence suggest a peripheral proinflammatory state and neuroinflammation in at least a third of patients with schizophrenia. Therefore, chemokines can be active players in these processes. In this systematic review, we analyzed the available data on chemokine dysregulation in schizophrenia and the association of chemokines with neuroinflammation. It has been shown that there is a genetic association of chemokine and chemokine receptor gene polymorphisms in schizophrenia. Besides, the most reliable data confirmed by the results of meta-analyses showed an increase in CXCL8/IL-8, CCL2/MCP-1, CCL4/MIP-1β, CCL11/eotaxin-1 in the blood of patients with schizophrenia. An increase in CXCL8 has been found in cerebrospinal fluid, but other chemokines have been less well studied. Increased/decreased expression of genes of chemokine and their receptors have been found in different areas of the brain and peripheral immune cells. The peripheral proinflammatory state may influence the expression of chemokines since their expression is regulated by pro- and anti-inflammatory cytokines. Mouse models have shown an association of schizophrenia with dysregulation of the CX3CL1-CX3CR1 and CXCL12-CXCR4 axes. Altogether, dysregulation in chemokine expression may contribute to neuroinflammation in schizophrenia. In conclusion, this evidence indicates the involvement of chemokines in the neurobiological processes associated with schizophrenia.
Competing Interests: The authors declare no conflict of interest.
References: J Psychiatr Res. 2020 Feb;121:31-38. (PMID: 31739114)
Mol Psychiatry. 2016 Aug;21(8):1090-8. (PMID: 26194183)
Mol Psychiatry. 2020 Apr;25(4):761-775. (PMID: 30214039)
Front Neurosci. 2022 Jun 30;16:858989. (PMID: 35844224)
Cytokines. 1992;4:131-52. (PMID: 1472914)
Schizophr Res. 2020 Dec;226:5-12. (PMID: 30967316)
Transl Psychiatry. 2019 May 23;9(1):151. (PMID: 31123247)
J Alzheimers Dis. 2016;51(2):417-25. (PMID: 26890750)
Transl Psychiatry. 2017 Aug 1;7(8):e1184. (PMID: 28763059)
Int J Mol Sci. 2021 Feb 04;22(4):. (PMID: 33557113)
J Neuroinflammation. 2020 Aug 23;17(1):247. (PMID: 32829711)
Schizophr Bull. 2019 Sep 11;45(5):1120-1133. (PMID: 30407606)
Nat Rev Immunol. 2002 Feb;2(2):106-15. (PMID: 11910892)
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:153-8. (PMID: 24495780)
Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18601-6. (PMID: 23091025)
Gene. 2018 May 20;656:80-85. (PMID: 29477870)
Brain Behav Immun. 2020 Aug;88:497-506. (PMID: 32283292)
Schizophr Res. 2015 Jan;161(1):102-12. (PMID: 24948485)
Transl Psychiatry. 2014 Feb 25;4:e365. (PMID: 24569695)
Pharmaceuticals (Basel). 2022 Feb 28;15(3):. (PMID: 35337097)
Schizophr Bull. 2018 Jan 13;44(1):75-83. (PMID: 28338954)
Immunol Invest. 2022 Aug;51(6):1843-1855. (PMID: 35476033)
Front Psychiatry. 2021 Jun 18;12:679960. (PMID: 34220586)
Asian J Psychiatr. 2020 Dec;54:102275. (PMID: 32663796)
Front Psychiatry. 2022 Apr 25;13:880568. (PMID: 35546942)
Front Immunol. 2018 Oct 10;9:2230. (PMID: 30364161)
Schizophr Res. 2015 Sep;167(1-3):12-7. (PMID: 25464914)
Schizophr Res. 2007 Jul;93(1-3):261-5. (PMID: 17490859)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
Curr Psychiatry Rep. 2019 Jul 3;21(8):72. (PMID: 31267432)
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:115-21. (PMID: 22192886)
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7612-6. (PMID: 7644464)
J Neurosci Res. 2004 Sep 15;77(6):858-66. (PMID: 15334603)
Biomedicines. 2022 Apr 05;10(4):. (PMID: 35453599)
Mol Psychiatry. 2021 Mar;26(3):849-863. (PMID: 31168068)
Biomed Res Int. 2019 Dec 2;2019:4042615. (PMID: 31886209)
Pharmaceuticals (Basel). 2020 Sep 02;13(9):. (PMID: 32887304)
World J Biol Psychiatry. 2011 Apr;12(3):201-15. (PMID: 21091092)
Neuropsychobiology. 2002;46(4):169-72. (PMID: 12566931)
Genes (Basel). 2022 Jul 04;13(7):. (PMID: 35885983)
Am J Psychiatry. 2015 Nov 1;172(11):1112-21. (PMID: 26133963)
Mol Psychiatry. 2021 Jul;26(7):3430-3443. (PMID: 33060818)
Biol Psychiatry. 2011 Oct 1;70(7):663-71. (PMID: 21641581)
Mol Psychiatry. 2016 Dec;21(12):1696-1709. (PMID: 26903267)
Dev Comp Immunol. 2004 May 3;28(5):443-60. (PMID: 15062643)
J Med Genet. 1997 Oct;34(10):798-804. (PMID: 9350810)
Schizophr Res. 2018 Dec;202:64-71. (PMID: 30025760)
J Mol Cell Cardiol. 2009 Jul;47(1):104-11. (PMID: 19328808)
Schizophr Res. 2018 Feb;192:247-254. (PMID: 28476335)
Psychiatry Clin Neurosci. 2010 Oct;64(5):587-8. (PMID: 20923436)
Brain Behav Immun. 2016 Nov;58:99-106. (PMID: 27235930)
Development. 2014 Nov;141(22):4199-205. (PMID: 25371357)
J Cereb Blood Flow Metab. 2010 Mar;30(3):459-73. (PMID: 19904283)
Neurosci Biobehav Rev. 2020 Jun;113:546-567. (PMID: 32320814)
Schizophr Res. 1995 Feb;14(3):223-8. (PMID: 7766533)
Psychiatr Genet. 2004 Jun;14(2):65-7. (PMID: 15167690)
Schizophr Res. 2015 Oct;168(1-2):434-43. (PMID: 26285829)
Schizophr Res. 2001 Apr 15;49(1-2):99-105. (PMID: 11343869)
Int J Mol Sci. 2019 Jan 30;20(3):. (PMID: 30704100)
Adv Clin Exp Med. 2021 Aug;30(8):775-778. (PMID: 34418336)
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17552-7. (PMID: 24101523)
J Neural Transm Gen Sect. 1992;89(3):219-32. (PMID: 1389005)
Curr Opin Hematol. 2018 Jan;25(1):44-51. (PMID: 28914666)
Int J Neuropsychopharmacol. 2018 Sep 1;21(9):828-836. (PMID: 30016466)
Pharmacol Rep. 2021 Aug;73(4):1063-1078. (PMID: 34021899)
Science. 2018 Feb 9;359(6376):693-697. (PMID: 29439242)
Brain Behav Immun. 2022 Feb;100:297-308. (PMID: 34875344)
Neurosci Biobehav Rev. 2014 May;42:93-115. (PMID: 24513303)
Cells. 2020 Jul 12;9(7):. (PMID: 32664639)
Mol Psychiatry. 2019 Jun;24(6):869-887. (PMID: 30116031)
Mol Neurobiol. 2016 Apr;53(3):1551-1564. (PMID: 25663168)
Nat Rev Neurosci. 2010 Jun;11(6):402-16. (PMID: 20485365)
Oxid Med Cell Longev. 2021 Jan 23;2021:8881770. (PMID: 33552387)
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7090-5. (PMID: 11983855)
Nature. 1998 Jun 11;393(6685):595-9. (PMID: 9634238)
Psychiatry Res. 2020 Nov;293:113421. (PMID: 32920525)
Mol Neurobiol. 2007 Oct;36(2):137-51. (PMID: 17952658)
Brain Behav Immun. 2022 Oct;105:149-159. (PMID: 35764269)
Cytokine. 2021 Oct;146:155640. (PMID: 34252872)
Schizophr Bull. 2017 Oct 21;43(6):1190-1196. (PMID: 28981842)
Transl Psychiatry. 2017 Mar 28;7(3):e1075. (PMID: 28350400)
Schizophr Res. 2019 Aug;210:221-227. (PMID: 30612841)
Brain Behav Immun. 2020 Nov;90:196-207. (PMID: 32798663)
Front Hum Neurosci. 2015 Sep 10;9:476. (PMID: 26441585)
Schizophr Res. 2018 Feb;192:255-261. (PMID: 28641886)
Nord J Psychiatry. 2016 Aug;70(6):407-12. (PMID: 26906930)
World J Biol Psychiatry. 2021 Feb;22(2):94-103. (PMID: 32295454)
Mol Psychiatry. 2016 Aug;21(8):1009-26. (PMID: 27271499)
Eur Arch Psychiatry Neurol Sci. 1987;236(5):257-9. (PMID: 3653145)
Br J Pharmacol. 2016 Feb;173(4):666-80. (PMID: 26455353)
Biochem Pharmacol. 2016 Aug 1;113:45-56. (PMID: 27206338)
Cytokine. 2016 Jan;77:227-37. (PMID: 26463515)
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9448-53. (PMID: 9689100)
Front Psychiatry. 2017 May 23;8:83. (PMID: 28588507)
Mol Psychiatry. 2013 Feb;18(2):206-14. (PMID: 22869038)
Biol Psychiatry. 1985 Oct;20(10):1039-46. (PMID: 4041510)
Front Mol Neurosci. 2018 Feb 08;11:13. (PMID: 29472840)
Transl Psychiatry. 2017 May 9;7(5):e1120. (PMID: 28485733)
BMJ. 2021 Mar 29;372:n160. (PMID: 33781993)
Development. 2014 May;141(9):1857-63. (PMID: 24718993)
Hum Mol Genet. 2006 Jun 15;15(12):1949-62. (PMID: 16687443)
Science. 2018 Dec 14;362(6420):. (PMID: 30545856)
Am J Psychiatry. 1999 Nov;156(11):1725-9. (PMID: 10553735)
Brain Behav Immun. 2018 Jul;71:28-36. (PMID: 29730395)
Psychoneuroendocrinology. 2021 May;127:105200. (PMID: 33740587)
Brain Behav Immun. 2020 Aug;88:547-558. (PMID: 32330592)
Brain Behav Immun Health. 2021 Oct 22;18:100370. (PMID: 34755124)
Cytokine. 2012 Jun;58(3):351-4. (PMID: 22425139)
Int J Mol Sci. 2020 Mar 31;21(7):. (PMID: 32244523)
Nat Rev Immunol. 2017 Jan;17(1):49-59. (PMID: 27916979)
Harv Rev Psychiatry. 2022 Jan-Feb 01;30(1):54-58. (PMID: 34995035)
Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):1-4. (PMID: 15389752)
J Clin Med. 2021 Aug 27;10(17):. (PMID: 34501305)
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:71-91. (PMID: 22765923)
معلومات مُعتمدة: 22-25-00633 Russian Science Foundation
فهرسة مساهمة: Keywords: CCL2; CCL4; CXCL8; IL-8; chemokines; cytokines; inflammation; neuroinflammation; receptor; schizophrenia
المشرفين على المادة: 0 (Chemokines)
0 (Cytokines)
0 (Chemokine CCL2)
0 (Chemokine CCL4)
0 (Chemokine CCL5)
تواريخ الأحداث: Date Created: 20230211 Date Completed: 20230214 Latest Revision: 20230214
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9917146
DOI: 10.3390/ijms24032215
PMID: 36768537
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms24032215